SOME of the changes that happen to a woman’s body during pregnancy are more obvious than others. We all know that women usually get a visible bump, they might have morning sickness initially, and swollen ankles later on, but pregnancy can also change some of their key bodily processes and functions too.
Women who suffer autoimmune diseases can also experience changes in their disease symptoms while they are pregnant. For example, women with multiple sclerosis and rheumatoid arthritis often feel better, while women with systemic lupus erythematosus often suffer worsening of their symptoms.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.
